S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7228 −0.33%
CLOSED · 18:35 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
HM
INSIDER · ABCL · AbCellera Biologics Inc. · DIRECTOR

Hayden Michael R

Every open-market transaction filed under this name, Aug 24 to Aug 24.

Filings
1
1 buy · 0 sells
Bought
$570K
open market, at cost
Sold
includes scheduled sales
Buys since
+16.5%
avg move from buy price, 1 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 24ABCLAbCellera Biologics Inc.DirectorBuy53,613$10.64$570K+16.5%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.